EyeYon Medical provides the only non-invasive medical device for the prevention and treatment of corneal edema, a common and painful eye disease. With the latest funding, they plan to develop a new product to make surgery obsolete
EyeYon Medical announced on Thursday that it raised $3.6 million in investment from TriVentures, Pontifax, a prominent Indian distributor, the Israeli Chief Scientist and existing investors. Founded by Dr. Ofer Daphna, senior ophthalmologist at the Kaplan Medical Center, and Dr. Arie Marcovich, a senior cornea surgeon, EyeYon Medical offers a noninvasive solution to corneal edema, a common, painful eye condition usually treated by topical medication and ointments, bandage contact lens (which can increase the chance of infection) or corneal transplant surgery.
The condition occurs when the thin, transparent cover of the eye becomes inflamed, often resulting from ocular surgery trauma, infection, swelling, and over-use of certain kinds of contact lenses. Corneal edema, or swelling, mostly affects people over the age 50, particularly women who have gone through menopause, as well as those with adverse reactions after ocular surgery.
Hey, check out all the engineering jobs. Post your resume today!
